Mid Atlantic is a clinical research site located in Philadelphia, Pennsylvania, United States 19006.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Mid Atlantic has participated in 1 clinical trials.
Therapeutic areas: Geographic Atrophy.
Sponsors: Apellis Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid Atlantic has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Atlantic has 1 clinical trials on record. Their work covers Geographic Atrophy.
Mid Atlantic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.